Arrowhead Pharmaceuticals Inc (ARWR)
R&D Expense Growth
14.41%
Quarterly · Period ending:
ARWR R&D Expense Growth
Latest reported14.41%period ending
Latest reported14.41%period ending
ARWR Quarterly R&D Growth (QoQ) (0.00% → 14.41%)
Latest values, visible window
High-resolution chart · PNG
ARWR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 14.4124% | |
| -2.2291% | |
| 1.4403% | |
| 7.5871% | |
| 21.9876% | |
| -2.8467% | |
| 4.2697% | |
| -11.3187% | |
| 52.7097% | |
| -13.8654% | |
| 16.8453% | |
| 4.9137% | |
| 26.5369% | |
| -10.801% | |
| 0.355% | |
| 15.9203% | |
| -5.1813% | |
| 16.0531% | |
| -3.3011% | |
| 10.8571% | |
| 32.727% | |
| 22.2733% | |
| -12.6847% | |
| 34.2242% | |
| 10.5085% | |
| 26.7802% | |
| -0.1981% | |
| 21.9407% | |
| -6.8033% | |
| 19.6892% | |
| 11.0301% | |
| 35.728% | |
| 0.2308% | |
| 28.7652% | |
| 1.8296% | |
| 19.9013% | |
| -1.0149% | |
| -26.7683% | |
| -18.3741% | |
| 23.8603% | |
| -5.9639% | |
| -3.0759% | |
| -0.4871% | |
| 38.7034% | |
| -65.6145% | |
| 22.7637% | |
| 110.7823% | |
| 31.6966% | |
| 22.5394% | |
| 66.4993% | |
| -3.5228% | |
| 84.877% | |
| -17.3406% | |
| 34.7793% | |
| -22.8811% | |
| 67.6838% | |
| -10.2639% | |
| 76.6658% | |
| 50.9083% | |
| 39.3887% | |
| 159.934% | |
| -93.7813% | |
| 787.5763% | |
| 106.6068% | |
| -45.0424% | |
| -19.2071% | |
| -72.6785% | |
| -59.4873% | |
| 66.5845% | |
| -61.2544% | |
| -30.9315% | |
| 68.0777% | |
| 98.1864% | |
| 1.5227% | |
| -74.0457% | |
| -25.1006% | |
| 91.7691% | |
| 200.1528% | |
| -67.9514% | |
| 337.567% | |
| -65.9716% | |
| 17.9468% | |
| 109.9769% | |
| -6.3905% | |
| 206.3017% | |
| -32.2374% | |
| 80.6216% | |
| 54.4595% | |
| 63.9383% | |
| 133.1852% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |